Literature DB >> 19697079

Epigenetics: deciphering how environmental factors may modify autoimmune type 1 diabetes.

Amanda J MacFarlane1, Alexander Strom, Fraser W Scott.   

Abstract

Type 1 diabetes (T1D) is an autoimmune disease that has increased two- to threefold over the past half century by as yet unknown means. It is generally accepted that T1D is the result of gene-environment interactions, but such rapid increases in incidence are not explained by Mendelian inheritance. There have been numerous advances in our knowledge of the pathogenesis of T1D. Indeed, there has been a large number of genes identified that contribute to risk for this disease and several environmental factors have been proposed. The complexity of such interactions is yet to be understood for any major chronic disease. Epigenetic regulation is one way to explain the rapid increase in incidence and could be a central mechanism by which environmental factors influence development of diabetes. However, there is remarkably little known about the contribution of epigenetics to T1D pathogenesis. Here we speculate on various candidate processes and molecules of the immune and endocrine systems that could modify risk for T1D through epigenetic regulation.

Entities:  

Mesh:

Year:  2009        PMID: 19697079     DOI: 10.1007/s00335-009-9213-6

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  90 in total

Review 1.  Epigenetic reprogramming in mammals.

Authors:  Hugh D Morgan; Fátima Santos; Kelly Green; Wendy Dean; Wolf Reik
Journal:  Hum Mol Genet       Date:  2005-04-15       Impact factor: 6.150

Review 2.  RNA meets chromatin.

Authors:  Emily Bernstein; C David Allis
Journal:  Genes Dev       Date:  2005-07-15       Impact factor: 11.361

3.  Inhibition of IFN-gamma transcription by site-specific methylation during T helper cell development.

Authors:  Brendan Jones; Jianzhu Chen
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

4.  Increased islet neogenesis without increased islet mass precedes autoimmune attack in diabetes-prone rats.

Authors:  Lisa M Kauri; Gen-Sheng Wang; Christopher Patrick; Mirella Bareggi; David J Hill; Fraser W Scott
Journal:  Lab Invest       Date:  2007-10-01       Impact factor: 5.662

5.  Effect of DNA methylation and chromatin structure on ITGAL expression.

Authors:  Qianjin Lu; Donna Ray; David Gutsch; Bruce Richardson
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

Review 6.  Epigenetics and T helper 1 differentiation.

Authors:  Thomas M Aune; Patrick L Collins; Shaojing Chang
Journal:  Immunology       Date:  2008-12-18       Impact factor: 7.397

7.  Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells.

Authors:  Gang Wei; Lai Wei; Jinfang Zhu; Chongzhi Zang; Jane Hu-Li; Zhengju Yao; Kairong Cui; Yuka Kanno; Tae-Young Roh; Wendy T Watford; Dustin E Schones; Weiqun Peng; Hong-Wei Sun; William E Paul; John J O'Shea; Keji Zhao
Journal:  Immunity       Date:  2009-01-16       Impact factor: 31.745

8.  Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat.

Authors:  R L Jacobs; J D House; M E Brosnan; J T Brosnan
Journal:  Diabetes       Date:  1998-12       Impact factor: 9.461

9.  Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes.

Authors:  Feng Miao; David D Smith; Lingxiao Zhang; Andrew Min; Wei Feng; Rama Natarajan
Journal:  Diabetes       Date:  2008-09-05       Impact factor: 9.461

10.  CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation.

Authors:  Hyoung-Pyo Kim; Warren J Leonard
Journal:  J Exp Med       Date:  2007-06-25       Impact factor: 14.307

View more
  23 in total

1.  Genomic imprinting in diabetes.

Authors:  Braxton D Mitchell; Toni I Pollin
Journal:  Genome Med       Date:  2010-08-23       Impact factor: 11.117

Review 2.  Type 1 diabetes in mice and men: gene expression profiling to investigate disease pathogenesis.

Authors:  Linda Yip; C Garrison Fathman
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

Review 3.  The prenatal environment and type 1 diabetes.

Authors:  L C Stene; E A M Gale
Journal:  Diabetologia       Date:  2013-05-10       Impact factor: 10.122

Review 4.  Epigenetics of the failing heart.

Authors:  José Marín-García; Alexander T Akhmedov
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

5.  Study of factors influencing susceptibility and age at onset of type 1 diabetes: A review of data from Continental Italy and Sardinia.

Authors:  Fulvia Gloria-Bottini; Patrizia Saccucci; Gian Franco Meloni; Maria Luisa Manca-Bitti; Luca Coppeta; Anna Neri; Andrea Magrini; Bottini Egidio
Journal:  World J Diabetes       Date:  2014-08-15

Review 6.  Type 1 diabetes and polyglandular autoimmune syndrome: A review.

Authors:  Martin P Hansen; Nina Matheis; George J Kahaly
Journal:  World J Diabetes       Date:  2015-02-15

7.  The recent rise in the frequency of type 1 diabetes: who pulled the trigger?

Authors:  Alia Hasham; Yaron Tomer
Journal:  J Autoimmun       Date:  2011-08       Impact factor: 7.094

8.  Epigenetic modulation of β cells by interferon-α via PNPT1/mir-26a/TET2 triggers autoimmune diabetes.

Authors:  Mihaela Stefan-Lifshitz; Esra Karakose; Lingguang Cui; Abora Ettela; Zhengzi Yi; Weijia Zhang; Yaron Tomer
Journal:  JCI Insight       Date:  2019-03-07

9.  DNA methylation profiles in type 1 diabetes twins point to strong epigenetic effects on etiology.

Authors:  Mihaela Stefan; Weijia Zhang; Erlinda Concepcion; Zhengzi Yi; Yaron Tomer
Journal:  J Autoimmun       Date:  2013-11-07       Impact factor: 7.094

10.  Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.

Authors:  P Achenbach; M Hummel; L Thümer; H Boerschmann; D Höfelmann; A G Ziegler
Journal:  Diabetologia       Date:  2013-03-29       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.